Emeryville, California – Berkeley Lights, Inc. (BLI), a pioneer and  leader in digital cell biology, today announced the appointment of Sarah Boyce, President of Akcea Therapeutics to the Berkeley Lights’ board of directors. Ms. Boyce brings over 25 years of commercial and clinical development expertise in the life sciences industry to this role along with a proven […]

Grant to Automate Variant Interpretation and Create Platform for Sharing Micropublications Across the Genomics Community Genomenon, Inc., the leading genomic search engine company, announced today that it was awarded a grant by the National Institutes of Health. The Small Business Innovation Research (SBIR) grant, awarded by the National Human Genome Research Institute*, will fund Genomenon’s […]

Nucleus Biologics now has the leading xeno-free, recombinant, extracellular matrix SAN DIEGO – Nucleus Biologics, a leader in precision cell culture, is pleased to announce the acquisition of Primorigen Biosciences, Inc. The addition of Primorigen’s Vitronectin XFTM and platform recombinant protein production technology will play a huge role in Nucleus’ strategy of offering traceable, reproducible and […]

Study to identify genomic markers associated with clinical response to ADCT-402 (loncastuximab tesirine) inrelapsed or refractory diffuse large B-cell lymphoma (DLBCL) Lausanne, Switzerland – ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and SOPHiA GENETICS, a leader in Data-Driven Medicine, today announced they have entered into […]

New Funding, Anticipated to Close at $22 Million, to Fuel Growth of its Regenerative Medicine MSC Manufacturing Platform Worldwide, Scale the Organization, and Accelerate R&D Innovation Frederick, MD, Aug. 6 — RoosterBio Inc, disrupting the market by radically simplifying human mesenchymal stem/stromal cell (hMSC) biomanufacturing, today announced it has raised in excess of $15 million in an initial Series B financing […]

FREIBURG, Germany — The owners of Cytena GmbH (“Cytena”) have agreed to sell all Cytena shares to CELLINK AB (“CELLINK”) for a purchase price of 30.25M euros (“acquisition”). Through CELLINK’s complimentary technology offering cytena sees great synergies that will support and accelerate future growth of Cytena. An extended product offering and a stronger global presence are just some of […]

MGI, a subsidiary of global genomics leader BGI Group, completed installation of its MGISEQ-2000RS genetic sequencer at the Genomic Research Laboratory, part of the Genome Technology Research Unit of BIOTEC – Thailand’s National Center for Genetic Engineering and Biotechnology. The milestone marks the first official installation of MGISEQ-2000 in Thailand, as well as the first […]

Amendments fortify the Agreement, allow revenue recognition, and strengthen the Applied DNA Balance Sheet STONY BROOK, N.Y. – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based (Polymerase Chain Reaction) DNA manufacturing for product authenticity and traceability solutions, today announced that the Company and TheraCann International Benchmark Corporation (“TheraCann”) have signed a […]

CELLINK AB (“CELLINK”) has entered an agreement with the owners of cytena GmbH (“cytena”) to acquire all cytena shares for a purchase price of 30.25M euros (“acquisition”). Through cytena’s complementary technology offering, CELLINK sees great synergies that will support future growth. cytena is the company CELLINK announced signing a LOI with in conjunction with raising capital in […]